Minitran (Glyceryl Trinitrate)

Minitran (glyceryl trinitrate) is used in the management of coronary artery disease and related angina syndromes.

• Chronic stable angina pectoris: reduces frequency of angina episodes and improves exercise tolerance.
• Prevention of angina attacks: provides continuous nitrate delivery to lessen sudden chest pain.
• Adjunct therapy in acute coronary syndrome: used alongside standard care to improve myocardial oxygen balance.

• Glyceryl trinitrate is a nitric oxide donor that releases NO in vascular smooth muscle. The generated nitric oxide activates guanylate cyclase, increasing cyclic GMP levels, which leads to relaxation of venous and arterial smooth muscle, decreasing preload and afterload and lowering myocardial oxygen demand.

Minitran may cause a range of adverse reactions, most of which are related to its vasodilatory properties.

Common Side Effects

• Headache: throbbing pain often occurring shortly after patch application.
• Dizziness or light‑headedness: due to transient blood pressure reduction.
• Flushing: warm sensation and reddening of the skin.
• Skin irritation at the patch site: redness, itching, or mild rash.
• Tachycardia: compensatory increase in heart rate.

Serious or Rare Side Effects

• Severe hypotension: marked drop in blood pressure that may cause syncope.
• Syncope: sudden loss of consciousness.
• Myocardial infarction: rare but reported in patients with unstable coronary disease.
• Severe allergic reaction: anaphylaxis or angioedema.
• Stevens‑Johnson syndrome or toxic epidermal necrolysis: rare severe skin reactions.
• Skin necrosis at the application site: uncommon but serious tissue damage.

Before prescribing Minitran, clinicians should consider several safety measures.

• Assess cardiovascular status: evaluate blood pressure and heart rate prior to initiation.
• Avoid concurrent use with phosphodiesterase‑5 inhibitors: risk of profound hypotension.
• Monitor for tolerance development: efficacy may diminish with continuous use.
• Educate patient on patch rotation: change site every 24 hours to reduce skin irritation.
• Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Minitran can interact with several drug classes, requiring careful management.

Major Interactions (Avoid)

• Sildenafil and other PDE‑5 inhibitors: can cause severe hypotension.
• Other nitrates (e.g., isosorbide dinitrate): additive vasodilatory effect leading to dangerous blood pressure drop.
• Alcohol: potentiates hypotensive effect.

Moderate Interactions (Monitor Closely)

• Antihypertensives (ACE inhibitors, beta‑blockers): may enhance blood pressure lowering.
• Diuretics: increase risk of orthostatic hypotension.
• Azole antifungals (e.g., ketoconazole): can raise nitrate plasma levels.